Diagnosing Pneumonia in Immunocompromised Hosts

Clinical Diagnostic Criteria

The American College of Physicians and Infectious Diseases Society of America recommend diagnosing pneumonia in immunocompromised patients when a new pulmonary infiltrate appears on chest imaging combined with any two of three clinical features: fever, leukocytosis or leukopenia, and purulent respiratory secretions 1, 2
The diagnosis is primarily clinical and should be made urgently, as development of pulmonary infiltrates in immunocompromised patients carries grave prognostic implications requiring immediate aggressive intervention 1
A new pulmonary infiltrate on imaging (chest radiograph or CT scan) is a key diagnostic criterion 3, 4
Fever (temperature >37.8°C), leukocytosis or leukopenia, and purulent respiratory secretions are the three clinical features used in diagnosis 2

The Infectious Diseases Society of America recommends that all patients with suspected pneumonia require chest imaging immediately 3, 5
An upright portable anteroposterior chest radiograph is the most feasible initial study 3, 4
CT scanning should be obtained when ruling out opportunistic infections in immunocompromised patients, standard chest radiographs are negative but clinical suspicion remains high, or detecting small nodular or cavitary lesions characteristic of opportunistic pathogens 3, 4, 6

The Centers for Disease Control and Prevention recommend that the nature and severity of immunodeficiency determines the diagnostic approach and likely pathogens 7
CD4+ >200 cells/μL with no systemic symptoms: Unlikely to have opportunistic infections; consider common community-acquired pathogens 7
CD4+ <200 cells/μL OR CD4+ >200 with unexplained fever, weight loss, or thrush: Suspect Pneumocystis jirovecii, tuberculosis, and other opportunistic infections 7

The Infectious Diseases Society of America recommends two sets of blood cultures (pretreatment) for hospitalized patients 5
Expectorated sputum for Gram stain and culture (deep-cough specimen obtained before antibiotics, rapidly transported and processed within hours) is recommended 5
Complete blood count, serum blood urea nitrogen, glucose, electrolytes, liver function tests, and oxygen saturation are also recommended 5
Bronchoscopy with bronchoalveolar lavage (BAL) should be performed when patients cannot produce adequate sputum, suspected opportunistic infections, pneumonia fails to respond to empiric therapy, or quantitative cultures are needed to distinguish colonization from true infection 1, 2, 3, 8

Endotracheal aspirates: ≥10⁶ CFU/mL 2
BAL: ≥10⁴ CFU/mL 2
Protected specimen brush: ≥10³ CFU/mL 2
These thresholds are only valid when samples are obtained >72 hours before antibiotic initiation or change 2

The yield of causative pathogens from BAL fluid using culture-based techniques for bacterial pathogens remains low even in symptomatic immunocompromised patients, according to the American Thoracic Society 9, 10, 11, 12

Routine testing for noninfluenza respiratory viruses is supported in the immunocompromised population given the high risk of progression from upper respiratory viral infection to fatal pneumonia, as recommended by the American Thoracic Society 9, 10, 11, 12
High-risk populations for viral testing include HSCT recipients, lung transplant recipients, patients actively receiving cancer chemotherapy, HIV infection with CD4 counts <500 cells/mm³, and solid organ transplant recipients, according to the American Thoracic Society 9, 10, 11, 12
The rate of progression from upper respiratory viral infection to fatal pneumonia is markedly higher in immunocompromised hosts than in nonimmunocompromised hosts, highlighting the importance of early detection and treatment, as noted by the American Thoracic Society 9, 10, 11, 12

The 2007 IDSA/ATS Criteria for Severe CAP should be used to assess severity, which includes either one major criterion or three or more minor criteria, as recommended by the Infectious Diseases Society of America and the American Thoracic Society 9, 10, 11, 12
Major criteria include septic shock with need for vasopressors and respiratory failure requiring mechanical ventilation, according to the Infectious Diseases Society of America and the American Thoracic Society 9, 10, 11, 12
Minor criteria include respiratory rate >30 breaths/min, PaO₂/FIO₂ ratio <250, multilobar infiltrates, confusion/disorientation, uremia, leukopenia, thrombocytopenia, hypothermia, and hypotension requiring aggressive fluid resuscitation, as defined by the Infectious Diseases Society of America and the American Thoracic Society 9, 10, 11, 12

Prolonged periods of viral shedding in immunocompromised hosts may lead to overdiagnosis and overtreatment in cases where viral inflammation is inactive or minimal, as noted by the American Thoracic Society 9, 10, 11, 12